Among these SNHGs, aberrant expression of SNHG4, located in 5q31.2, has been reported in various human malignancies, such as prostate cancer, osteosarcoma, cervical cancer, and hepatocellular carcinoma [17–21]. This evidence concerns the gene SNHG4 and prostate cancer.